The regulation of pre- and post-maturational plasticity of mammalian islet cell mass

Diabetologia

Volumn 57, Issue 7, 2014, Pages 1291-1303

  Mezza, Teresa ^a,b,c   Kulkarni, Rohit N ^a,b  

^a JOSLIN DIABETES CENTER   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

^c CATHOLIC UNIVERSITY   (Italy)

Author keywords

Ageing; Alpha cell plasticity; Beta cell mass; Beta cell maturation; Microbiome; Review

Indexed keywords

CHOLECYSTOKININ; EPIDERMAL GROWTH FACTOR; GASTRIC INHIBITORY POLYPEPTIDE; GASTRIN; GLUCAGON; GLUCAGON LIKE PEPTIDE 1; GLUCOSE; INSULIN; LIPID; MICRORNA; PLACENTA LACTOGEN; PLATELET DERIVED GROWTH FACTOR; PROTEIN; SOMATOMEDIN B; SOMATOMEDIN C;

ADOLESCENCE; ADULTHOOD; AGE; APOPTOSIS; CELL CYCLE REGULATION; CELL MATURATION; CELL PROLIFERATION; CELL REGENERATION; CHRONOBIOLOGY; GLUCOSE HOMEOSTASIS; GLUCOSE INFUSION; HORMONAL REGULATION; HORMONE RELEASE; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN RELEASE; INSULIN RESISTANCE; INSULIN SENSITIVITY; ISLET CELL PLASTICITY; LIPID DIET; MICROBIOME; NEWBORN PERIOD; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OXIDATIVE STRESS; PANCREAS ISLET; PANCREAS ISLET ALPHA CELL; PANCREAS ISLET BETA CELL; PANCREAS ISLET CELL; PANCREAS ISLET CELL FUNCTION; PLASTICITY; PRENATAL PERIOD; PRIORITY JOURNAL; PROTEIN DIET; PUBERTY; REVIEW; SENESCENCE; SIGNAL TRANSDUCTION; ANIMAL; CYTOLOGY; GROWTH, DEVELOPMENT AND AGING; METABOLISM; PHYSIOLOGY;

ANIMALS; HUMANS; INSULIN; INSULIN-SECRETING CELLS; ISLETS OF LANGERHANS; SIGNAL TRANSDUCTION;

EID: 84903524188     PISSN: 0012186X     EISSN: 14320428     Source Type: Journal    
DOI: 10.1007/s00125-014-3251-7     Document Type: Review

References (149)

1. Weir GC, Bonner-Weir S (2013) Islet β cell mass in diabetes and how it relates to function, birth, and death. Ann N YAcad Sci 1281:92-105
2. Teo AK, Wagers AJ, Kulkarni RN (2013) New opportunities: harnessing induced pluripotency for discovery in diabetes and metabolism. Cell Metab 18:775-791
3. Talchai C, Xuan S, Lin HV, Sussel L, Accili D (2012) Pancreatic β cell dedifferentiation as a mechanism of diabetic β cell failure. Cell 150:1223-1234
4. El Ouaamari A, Kawamori D, Dirice E et al (2013) Liver-derived systemic factors drive β cell hyperplasia in insulin-resistant states. Cell Rep 3:401-410
5. Yi P, Park JS, Melton DA (2013) Betatrophin: a hormone that controls pancreatic β cell proliferation. Cell 153:747-758
6. Dor Y, Brown J, Martinez OI, Melton DA (2004) Adult pancreatic beta-cells are formed by self-duplication rather than stem-cell differentiation. Nature 429:41-46 (Pubitemid 38620543)
7. Xu X, D'Hoker J, Stangé G et al (2008) Beta cells can be generated from endogenous progenitors in injured adult mouse pancreas. Cell 132:197-207 (Pubitemid 351181232)
8. Kulkarni RN, Mizrachi EB, Ocana AG, Stewart AF (2012) Human β-cell proliferation and intracellular signaling: driving in the dark without a road map. Diabetes 61:2205-2213
9. Müller WA, Faloona GR, Aguilar-Parada E, Unger RH (1970) Abnormal alpha-cell function in diabetes. Response to carbohydrate and protein ingestion. N Engl J Med 283:109-115
10. Dunning BE, Gerich JE (2007) The role of alpha-cell dysregulation in fasting and postprandial hyperglycemia in type 2 diabetes and therapeutic implications. Endocr Rev 28:253-283 (Pubitemid 46984828)
11. Braun M, Rorsman P (2010) The glucagon-producing alpha cell: an electrophysiologically exceptional cell. Diabetologia 53:1827-1830
12. Collombat P, Xu X, Ravassard P et al (2009) The ectopic expression of Pax4 in the mouse pancreas converts progenitor cells into alpha and subsequently beta cells. Cell 138:449-462
13. Thorel F, Népote V, Avril I et al (2010) Conversion of adult pancreatic alpha-cells to beta-cells after extreme beta-cell loss. Nature 464:1149-1154
14. Juhl K, Bonner-Weir S, Sharma A (2010) Regenerating pancreatic beta-cells: plasticity of adult pancreatic cells and the feasibility of invivo neogenesis. Curr Opin Organ Transplant 1581:79-85
15. Bonner-Weir S (2001) Beta-cell turnover: its assessment and implications. Diabetes 50(Suppl 1):S20-S24
16. Scaglia L, Cahill CJ, Finegood DT, Bonner-Weir S (1997) Apoptosis participates in the remodeling of the endocrine pancreas in the neonatal rat. Endocrinology 138:1736-1741 (Pubitemid 27137129)
17. Quinn AR, Blanco CL, Perego C et al (2012) The ontogeny of the endocrine pancreas in the fetal/newborn baboon. J Endocrinol 214:289-299
18. Heremans Y, van de Casteele M, in 't Veld P et al (2002) Recapitulation of embryonic neuroendocrine differentiation in adult human pancreatic duct cells expressing neurogenin 3. J Cell Biol 159:303-312
19. Apelqvist A, Li H, Sommer L et al (1999) Notch signalling controls pancreatic cell differentiation. Nature 400:877-881 (Pubitemid 29406724)
20. Bernard-Kargar C, Ktorza A (2001) Endocrine pancreas plasticity under physiological and pathological conditions. Diabetes 50(Suppl 1):S30-S35 (Pubitemid 32148212)
21. Gregg BE, Moore PC, Demozay D et al (2012) Formation of a human β- cell population within pancreatic islets is set early in life. J Clin Endocrinol Metab 97:3197-3206
22. Meier JJ, Köhler CU, Alkhatib B et al (2010) Beta-cell development and turnover during prenatal life in humans. Eur J Endocrinol 162:559-568
23. Bouwens L, Lu WG, de Krijger R (1997) Proliferation and differentiation in the human fetal endocrine pancreas. Diabetologia 40:398-404 (Pubitemid 27132610)
24. Ackermann AM, Gannon M (2007) Molecular regulation of pancreatic beta-cell mass development, maintenance, and expansion. J Mol Endocrinol 38:193-206 (Pubitemid 46351603)
25. Zhang H, Ackermann AM, Gusarova GA et al (2006) The FoxM1 transcription factor is required tomaintain pancreatic beta-cell mass. Mol Endocrinol 20:1853-1866 (Pubitemid 44148089)
26. Prasadan K, Daume E, Preuett B et al (2002) Glucagon is required for early insulin-positive differentiation in the developing mouse pancreas. Diabetes 51:3229-3236 (Pubitemid 35246969)
27. Gromada J, Franklin I, Wollheim CB (2007) Alpha-cells of the endocrine pancreas: 35 years of research but the enigma remains. Endocr Rev 28:84-116 (Pubitemid 46220851)
28. Kawamori D, Kurpad AJ, Hu J et al (2009) Insulin signaling in alpha cells modulates glucagon secretion in vivo. Cell Metab 9:350-361
29. Gelling RW, Du XQ, Dichmann DS et al (2003) Lower blood glucose, hyperglucagonemia, and pancreatic alpha cell hyperplasia in glucagon receptor knockout mice. Proc Natl Acad Sci U S A 100:1438-1443 (Pubitemid 36184020)
30. Vincent M, Guz Y, RozenbergMet al (2003) Abrogation of protein convertase2 activity results in delayed islet cell differentiation and maturation, increased alpha-cell proliferation, and islet neogenesis. Endocrinology 144:4061-4069 (Pubitemid 37088761)
31. Lu J, Herrera PL, Carreira C, Bonnavion R et al (2010) Alpha cell-specific Men1 ablation triggers the transdifferentiation of glucagon-expressing cells and insulinoma development. Gastroenterology 138:1954-1965
32. Wilcox CL, Terry NA, Walp ER, Lee RA, May CL (2013) Pancreatic α-cell specific deletion of mouse Arx leads to α-cell identity loss. PLoS One 8:e66214. doi:10.1371/journal.pone.0066214
33. Mastracci TL, Wilcox CL, Arnes L et al (2011) Nkx2.2 and Arx genetically interact to regulate pancreatic endocrine cell development and endocrine hormone expression. Dev Biol 359:1-11
34. Hill DJ (2011) Nutritional programming of pancreatic β-cell plasticity. World J Diabetes 2:119-126
35. Gesina E, Blondeau B, Milet A et al (2006) Glucocorticoid signalling affects pancreatic development through both direct and indirect effects. Diabetologia 49:2939-2947 (Pubitemid 44730297)
36. Reusens B, Remacle C (2006) Programming of the endocrine pancreas by the early nutritional environment. Int J Biochem Cell Biol 38:913-922 (Pubitemid 43363421)
37. Elmes MJ, Gardner DS, Langley-Evans SC (2007) Fetal exposure to a maternal low-protein diet is associated with altered left ventricular pressure response to ischaemia-reperfusion injury. Br J Nutr 98:93-100 (Pubitemid 47272151)
38. Sathishkumar K, Elkins R, Yallampalli U, Yallampalli C (2009) Protein restriction during pregnancy induces hypertension and impairs endothelium-dependent vascular function in adult female offspring. J Vasc Res 46:229-239
39. Brissova M, Aamodt K, Brahmachary P et al (2014) Islet microenvironment, modulated by vascular endothelial growth factor-a signaling, promotes β cell regeneration. Cell Metab. doi:10.1016/j.cmet.2014.02.001
40. Nolan CJ, Damm P, Prentki M (2011) Type 2 diabetes across generations: from pathophysiology to prevention and management. Lancet 378:169-181
41. Banerji MA (2002) Impaired beta-cell and alpha-cell function in African-American children with type 2 diabetes mellitus-"Flatbush diabetes". J Pediatr Endocrinol Metab 15(Suppl 1):493-501 (Pubitemid 34704757)
42. SEARCH for Diabetes in Youth Study Group, Liese AD, D'Agostino RB Jr, Hamman RF et al (2006) The burden of diabetes mellitus among US youth: prevalence estimates from the SEARCH for Diabetes in Youth Study. Pediatrics 118:1510-1518
43. Baranowski T, Cooper DM, Harrell J et al (2006) Presence of diabetes risk factors in a large U.S. eighth-grade cohort. Diabetes Care 29:212-217
44. GoranMI, GowerBA (2001) Longitudinal study on pubertal insulin resistance. Diabetes 50:2444-2450 (Pubitemid 33642760)
45. Caprio S, Plewe G, Diamond MP et al (1989) Increased insulin secretion in puberty: a compensatory response to reductions in insulin sensitivity. J Pediatr 114:963-967 (Pubitemid 19151751)
46. Arslanian SA, Kalhan SC (1995) Correlations between fatty acid and glucose metabolism: potential explanation of insulin resistance of puberty. Diabetes 43:908-914 (Pubitemid 24196424)
47. Amiel SA, Sherwin RS, Simonson DC, Lauritano AA, Tamborlane WV (1986) Impaired insulin action in puberty: a contributing factor to poor glycemic control in adolescents with diabetes. N Engl J Med 315:215-219 (Pubitemid 16097122)
48. Merimee TJ, Burgess JA, Rabinowitz D (1967) Influence of growth hormone on insulin secretion. Diabetes 16:478-482
49. Nielsen JH (1982) Effects of growth hormone, prolactin, and placental lactogen on insulin content and release, and deoxyribonucleic acid synthesis in cultured pancreatic islets. Endocrinology 110:600-606
50. Meier JJ, Butler AE, Saisho Yet al (2008) Beta-cell replication is the primary mechanism subserving the postnatal expansion of beta-cell mass in humans. Diabetes 57:1584-1594
51. Saisho Y, Butler AE, Meier JJ et al (2007) Pancreas volumes in humans from birth to age one hundred taking into account sex, obesity, and presence of type-2 diabetes. Clin Anat 20:933-942 (Pubitemid 350074312)
52. Kassem SA, Ariel I, Thornton PS, Scheimberg I, Glaser B (2000) Beta-cell proliferation and apoptosis in the developing normal human pancreas and in hyperinsulinism of infancy. Diabetes 49:1325-1333 (Pubitemid 30624233)
53. Gepts W, de Mey J (1978) Islet cell survival determined by morphology. An immunocytochemical study of the islets of Langerhans in juvenile diabetes mellitus. Diabetes 27(Suppl 1):251-261 (Pubitemid 8303582)
54. Hill DJ, Hogg J (1991) Growth factor control of pancreatic B cell hyperplasia. Baillieres Clin Endocrinol Metab 5:689-698
55. Kawamori D, Akiyama M, Hu J, Hambro B, Kulkarni RN (2011) Growth factor signalling in the regulation of α- cell fate. Diabetes Obes Metab 13(Suppl 1):21-30
56. Martín J, Hunt SL, Dubus P et al (2003) Genetic rescue of Cdk4 null mice restores pancreatic beta-cell proliferation but not homeostatic cell number. Oncogene 22:5261-5269 (Pubitemid 37056088)
57. Kushner JA, Ciemerych MA, Sicinska E et al (2005) Cyclins D2 and D1 are essential for postnatal pancreatic beta-cell growth. Mol Cell Biol 25:3752-3762 (Pubitemid 40559580)
58. Georgia S, Bhushan A (2004) Beta cell replication is the primary mechanism for maintaining postnatal beta cell mass. J Clin Invest 114:963-968 (Pubitemid 39578724)
59. Uchida T, Nakamura T, Hashimoto N et al (2005) Deletion of Cdkn1b ameliorates hyperglycemia by maintaining compensatory hyperinsulinemia in diabetic mice. Nat Med 11:175-182 (Pubitemid 40321353)
60. Kassem SA, Ariel I, Thornton PS (2001) p57KIP2 expression in normal islet cells and in hyperinsulinism of infancy. Diabetes 50:2763-2769 (Pubitemid 33733127)
61. Ackermann Misfeldt A, Costa RH, Gannon M (2008) Beta-cell proliferation, but not neogenesis, following 60% partial pancreatectomy is impaired in the absence of FoxM1. Diabetes 57:3069-3077
62. Zarrouki B, Benterki I, Fontés G et al (2014) Epidermal growth factor receptor signaling promotes pancreatic β-cell proliferation in response to nutrient excess in rats through mTOR and FOXM1. Diabetes 63:982-993
63. Crabtree JS, Scacheri PC, Ward JM et al (2003) Of mice and MEN1: insulinomas in a conditional mouse knockout. Mol Cell Biol 23:6075-6085 (Pubitemid 37013087)
64. Karnik SK, Hughes CM, Gu X et al (2005) Menin regulates pancreatic islet growth by promoting histone methylation and expression of genes encoding p27kip1 p27 kip1 and p18INK4c. Proc Natl Acad Sci U S A 102:14659-14664 (Pubitemid 41457112)
65. Al-Hasani K, Pfeifer A, Courtney M et al (2013) Adult duct-lining cells can reprogram into β-like cells able to counter repeated cycles of toxin-induced diabetes. Dev Cell 26:86-100
66. Kulkarni RN, Brüning JC, Winnay JN, Postic C, Magnuson MA, Kahn CR (1999) Tissue-specific knockout of the insulin receptor in pancreatic beta cells creates an insulin secretory defect similar to that in type 2 diabetes. Cell 96:329-339 (Pubitemid 29077587)
67. Kulkarni RN, Holzenberger M, Shih DQ et al (2002) Beta-cellspecific deletion of the Igf1 receptor leads to hyperinsulinemia and glucose intolerance but does not alter beta-cell mass. Nat Genet 31:111-115
68. Withers DJ, Gutierrez JS, Towery H et al (1998) Disruption of IRS-2 causes type 2 diabetes in mice. Nature 391:900-904 (Pubitemid 28157668)
69. Cantley J, Choudhury AI, Asare-Anane H et al (2007) Pancreatic deletion of insulin receptor substrate 2 reduces beta and alpha cell mass and impairs glucose homeostasis in mice. Diabetologia 50:1248-1256 (Pubitemid 46701548)
70. Cho H, Mu J, Kim JK et al (2001) Insulin resistance and a diabetes mellitus-like syndrome in mice lacking the protein kinase Akt2 (PKBβ). Science 292:1728-1731 (Pubitemid 32506248)
71. Hagiwara S, Sakurai T, Tashiro F et al (1995) An inhibitory role for phosphatidylinositol 3-kinase in insulin secretion from pancreatic B cell line MIN6. Biochem Biophys Res Commun 214:51-59
72. Martinez SC, Tanabe K, Cras-Méneur C, Abumrad NA, Bernal-Mizrachi E, Permutt MA (2008) Inhibition of Foxo1 protects pancreatic islet beta-cells against fatty acid and endoplasmic reticulum stress-induced apoptosis. Diabetes 57:846-859
73. Mezza T, Muscogiuri G, Sorice GP et al (2014) Insulin resistance alters islet morphology in non-diabetic humans. Diabetes 63:994-1007
74. Yoon KH, Ko SH, Cho JH et al (2003) Selective beta-cell loss and alpha-cell expansion in patients with type 2 diabetes mellitus in Korea. J Clin Endocrinol Metab 88:2300-2308 (Pubitemid 36549911)
75. Orci L, Baetens D, Rufener C et al (1976) Hypertrophy and hyperplasia of somatostatin-containing D-cells in diabetes. Proc Natl Acad Sci U S A 73:1338-1342
76. Liang Y, Osborne MC, Monia BP et al (2004) Reduction in glucagon receptor expression by an antisense oligonucleotide ameliorates diabetic syndrome in db/db mice. Diabetes 53:410-417 (Pubitemid 38174557)
77. Chen M, Gavrilova O, Zhao WQ et al (2005) Increased glucose tolerance and reduced adiposity in the absence of fasting hypoglycemia in mice with liver-specific Gs alpha deficiency. J Clin Invest 115:3217-3227 (Pubitemid 41567586)
78. Liu Z, Kim W, Chen Z et al (2011) Insulin and glucagon regulate pancreatic alpha cell proliferation. PLoS One 6:e16096
79. Longuet C, Robledo AM, Dean ED et al (2013) Liver-specific disruption of the murine glucagon receptor produces α-cell hyperplasia: evidence for a circulating α-cell growth factor. Diabetes 62:1196-1205
80. Guardado-Mendoza R, Jimenez-Ceja L, Majluf-Cruz A et al (2013) Impact of obesity severity and duration on pancreatic β- and α-cell dynamics in normoglycemic non-human primates. Int J Obes (Lond) 37:1071-1078
81. Bernard C, Berthault MF, Saulnier C, Ktorza A (1999) Neogenesis vs. apoptosis as main components of pancreatic beta cell mass changes in glucose-infused normal and mildly diabetic adult rats. FASEB J 13:1195-1205 (Pubitemid 29300365)
82. Paris M, Bernard-Kargar C, Berthault MF, Bouwens L, Ktorza A (2003) Specific and combined effects of insulin and glucose on functional pancreatic beta-cell mass in vivo in adult rats. Endocrinology 144:2717-2727 (Pubitemid 36629925)
83. Hoorens A, van de Casteele M, Klöppel G, Pipeleers D (1996) Glucose promotes survival of rat pancreatic beta cells by activating synthesis of proteins which suppress a constitutive apoptotic program. J Clin Invest 98:1568-1574 (Pubitemid 26327866)
84. Porat S, Weinberg-Corem N, Tornovsky-Babaey S (2011) Control of pancreatic β cell regeneration by glucosemetabolism. Cell Metab 13:440-449
85. Maedler K, Sergeev P, Ris F et al (2002) Glucose-induced β cell production of IL-1β contributes to glucotoxicity in human pancreatic islets. J Clin Invest 110:851-860
86. Rossetti L, Giaccari A, DeFronzo RA (1990) Glucose toxicity. Diabetes Care 13:610-630 (Pubitemid 20169143)
87. Morley MG, Leiter EH, Eisenstein AB, Strack I (1982) Dietary modulation of alpha cell volume and function in strain 129/J mice. Am J Physiol 242:G354-G359 (Pubitemid 12097133)
88. Ellingsgaard H, Ehses JA, Hammar EB et al (2008) Interleukin-6 regulates pancreatic alpha-cell mass expansion. Proc Natl Acad Sci U S A 105:13163-13168
89. Bartel DP (2004) MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 16:281-297
90. Guay C, Jacovetti C, Nesca V, Motterle A, Tugay K, Regazzi R (2012) Emerging roles of non-coding RNAs in pancreatic β-cell function and dysfunction. Diabetes Obes Metab 14(Suppl 3):12-21
91. Esguerra JL, Bolmeson C, Cilio CM, Eliasson L (2011) Differential glucose-regulation of microRNAs in pancreatic islets of non-obese type 2 diabetes model Goto-Kakizaki rat. PLoS One 6:e18613
92. Jacovetti C, Abderrahmani A, Parnaud G et al (2012) MicroRNAs contribute to compensatory β cell expansion during pregnancy and obesity. J Clin Invest 122:3541-3551
93. Nesca V, Guay C, Jacovetti C et al (2013) Identification of particular groups of microRNAs that positively or negatively impact on beta cell function in obese models of type 2 diabetes. Diabetologia 56:2203-2212
94. Tattikota SG, Rathjen T, McAnulty SJ et al (2014) Argonaute2 mediates compensatory expansion of the pancreatic β cell. Cell Metab 19:122-134
95. Wang Y, Liu J, Liu C, Naji A, Stoffers DA (2013) MicroRNA-7 regulates the mTOR pathway and proliferation in adult pancreatic β-cells. Diabetes 62:887-895
96. Poy MN, Eliasson L, Krutzfeldt J et al (2004) A pancreatic islet-specific microRNA regulates insulin secretion. Nature 432:226-230 (Pubitemid 39545853)
97. Poy MN, Hausser J, Trajkovski M et al (2009) miR-375 maintains normal pancreatic alpha- and beta-cellmass. Proc Natl Acad SciUSA 106:5813-5818
98. Freemark M, Avril I, Fleenor D et al (2002) Targeted deletion of the PRL receptor: effects on islet development, insulin production, and glucose tolerance. Endocrinology 143:1378-1385 (Pubitemid 34274368)
99. Terra LF, Garay-Malpartida MH, Wailemann RA, Sogayar MC, Labriola L (2011) Recombinant human prolactin promotes human beta cell survival via inhibition of extrinsic and intrinsic apoptosis pathways. Diabetologia 54:1388-1397
100. Kondegowda NG, Mozar A, Chin C, Otero A, Garcia-Ocaña A, Vasavada RC (2012) Lactogens protect rodent and human beta cells against glucolipotoxicity-induced cell death through Janus kinase-2 (JAK2)/signal transducer and activator of transcription-5 (STAT5) signalling. Diabetologia 55:1721-1732
101. Laube H, Fussgänger RD, Schröder KE, Pfeiffer EF (1972) Acute effects of human chorionic somatomammotropin on insulin and glucagon release in the isolated perfused pancreas. Diabetes 21:1072-1076
102. Koiter TR, Faas MM, Visscher A, Kievit C, Steffens AB, Schuiling GA (1992) Regulation of peripheral glucagon concentrations in cyclic, pregnant, and lactating rats. Physiol Behav 51:1173-1178
103. Luyckx AS, Gerard J, Gaspard U, Lefebvre PJ (1975) Plasma glucagon levels in normal women during pregnancy. Diabetologia 11:549-554
104. Farilla L, Hui H, Bertolotto C et al (2002) Glucagon-like peptide-1 promotes islet cell growth and inhibits apoptosis in Zucker diabetic rats. Endocrinology 143:4397-4408 (Pubitemid 35239574)
105. Widenmaier SB, Kim SJ, Yang GK et al (2010) A GIP receptor agonist exhibits beta-cell anti-apoptotic actions in rat models of diabetes resulting in improved beta-cell function and glycemic control. PLoS One 5:e9590
106. Kuntz E, Pinget M, Damgé P (2004) Cholecystokinin octapeptide: a potential growth factor for pancreatic beta cells in diabetic rats. JOP 5:464-475 (Pubitemid 41573849)
107. Rooman I, Lardon J, Bouwens L (2002) Gastrin stimulates beta-cell neogenesis and increases islet mass from transdifferentiated but not from normal exocrine pancreas tissue. Diabetes 51:686-690 (Pubitemid 34760176)
108. Lavine JA, Attie AD (2010) Gastrointestinal hormones and the regulation of β-cell mass. Ann N YAcad Sci 1212:41-58
109. Favaro E, Granata R, Miceli I et al (2012) The ghrelin gene products and exendin-4 promote survival of human pancreatic islet endothelial cells in hyperglycaemic conditions, through phosphoinositide 3-kinase/Akt, extracellular signal-related kinase (ERK)1/2 and cAMP/protein kinase A (PKA) signalling pathways. Diabetologia 55:1058-1070
110. Tschen SI, Dhawan S, Gurlo T, Bhushan A (2009) Age-dependent decline in beta-cell proliferation restricts the capacity of beta-cell regeneration in mice. Diabetes 58:1312-1320
111. Stephens SB, Schisler JC, Hohmeier HE et al (2012) A VGF-derived peptide attenuates development of type 2 diabetes via enhancement of islet β - cell survival and function. Cell Metab 16:33-43
112. Akarte AS, Srinivasan BP, Gandhi S, Sole S (2012) Chronic DPP-IV inhibition with PKF-275-055 attenuates inflammation and improves gene expressions responsible for insulin secretion in streptozotocin induced diabetic rats. Eur J Pharm Sci 47:456-463
113. Chia CW, Carlson OD, Kim W et al (2009) Exogenous glucose-dependent insulinotropic polypeptide worsens post prandial hyperglycemia in type 2 diabetes. Diabetes 58:1342-1349
114. Drucker DJ (2013) Incretin action in the pancreas: potential promise, possible perils, and pathological pitfalls. Diabetes 62:3316-3323
115. Butler AE, Campbell-ThompsonMet al (2013)Marked expansion of exocrine and endocrine pancreas with incretin therapy in humans with increased exocrine pancreas dysplasia and the potential for glucagon-producing neuroendocrine tumors. Diabetes 62:2595-2604
116. Nyborg NC, Molck AM, Madsen LW, Bjerre Knudsen L (2012) The human GLP-1 analog liraglutide and the pancreas: evidence for the absence of structural pancreatic changes in three species. Diabetes 61:1243-1249
117. Busch SJ, Hoffmann P, Sahota P et al (2013) Studies in rodents with the dipeptidyl peptidase-4 inhibitor vildagliptin to evaluate possible drug-induced pancreatic histological changes that are predictive of pancreatitis and cancer development in man. Diabetes Obes Metab 15:72-76
118. Ali S, Lamont BJ, CharronMJ, Drucker DJ (2011) Dual elimination of the glucagon and GLP-1 receptors in mice reveals plasticity in the incretin axis. J Clin Invest 121:1917-1929
119. Saisho Y, Butler AE, Manesso E, Elashoff D, Rizza RA, Butler PC (2012) β-Cell mass and turnover in humans: effects of obesity and aging. Diabetes Care 36:111-117
120. Cnop M, Hughes SJ, Igoillo-Esteve M et al (2010) The long lifespan and low turnover of human islet beta cells estimated by mathematical modelling of lipofuscin accumulation. Diabetologia 53:321-330
121. Perl S, Kushner JA, Buchholz BA et al (2010) Significant human beta-cell turnover is limited to the first three decades of life as determined by in vivo thymidine analog incorporation and radiocarbon dating. J Clin Endocrinol Metab 95:E234-E239
122. Kohler CU, Olewinski M, Tannapfel A, Schmidt WE, Fritsch H, Meier JJ (2011) Cell cycle control of beta-cell replication in the prenatal and postnatal human pancreas. Am J Physiol Endocrinol Metab 300:E221-E230
123. Butler AE, Janson J, Bonner-Weir S, Ritzel R, Rizza RA, Butler PC (2003) Beta-cell deficit and increased beta-cell apoptosis in humans with type 2 diabetes. Diabetes 52:102-110 (Pubitemid 36042113)
124. Reers C, Erbel S, Esposito I et al (2009) Impaired islet turnover in human donor pancreata with aging. Eur J Endocrinol 160:185-191
125. Law E, Lu S, Kieffer TJ et al (2010) Differences between amyloid toxicity in alpha and beta cells in human and mouse islets and the role of caspase-3. Diabetologia 53:1415-1427
126. Verchere CB, D'Alessio DA, Palmiter RD et al (1996) Islet amyloid formation associated with hyperglycemia in transgenic mice with pancreatic beta cell expression of human islet amyloid polypeptide. Proc Natl Acad Sci U S A 93:3492-3496 (Pubitemid 26125648)
127. Janson J, Ashley RH, Harrison D, McIntyre S, Butler PC (1999) The mechanism of islet amyloid polypeptide toxicity is membrane disruption by intermediate-sized toxic amyloid particles. Diabetes 48:491-498 (Pubitemid 29106861)
128. Guardado-Mendoza R, Davalli AM, Chavez AO et al (2009) Pancreatic islet amyloidosis, beta-cell apoptosis, and alpha-cell proliferation are determinants of islet remodeling in type-2 diabetic baboons. Proc Natl Acad Sci U S A 106:13992-13997
129. Krishnamurthy J, Torrice C, Ramsey MR et al (2004) Ink4a/Arf expression is a biomarker of aging. J Clin Invest 114:1299-1307 (Pubitemid 40385301)
130. Krishnamurthy J, Ramsey MR, Ligon KL et al (2006) p16INK4a induces an age-dependent decline in islet regenerative potential. Nature 443:453-457 (Pubitemid 44477281)
131. Omori S, Tanaka Y, Takahashi A et al (2008) Association of CDKAL1, IGF2BP2, CDKN2A/B, HHEX, SLC30A8, and KCNJ11 with susceptibility to type 2 diabetes in a Japanese population. Diabetes 57:791-795
132. Zeggini E, Weedon MN, Lindgren CM et al (2007) Replication of genome-wide association signals in UK samples reveals risk loci for type 2 diabetes. Science 316:1336-1341 (Pubitemid 46871654)
133. Diabetes Genetics Initiative of Broad Institute of Harvard and MIT, Lund University, and Novartis Institutes of BioMedical Research, Saxena R, Voight BF et al (2007)Genome-wide association analysis identifies loci for type 2 diabetes and triglyceride levels. Science 316:1331-1336
134. Grarup N, Rose CS, Andersson EA et al (2007) Studies of association of variants near the HHEX, CDKN2A/B, and IGF2BP2 genes with type 2 diabetes and impaired insulin release in 10,705 Danish subjects: validation and extension of genome-wide association studies. Diabetes 56:3105-3111 (Pubitemid 350223649)
135. Dhawan S, Tschen SI, BhushanA(2009) Bmi-1 regulates the Ink4a/Arf locus to control pancreatic beta-cell proliferation. Genes Dev 23:906-911
136. Chen H, Gu X, Su IH et al (2009) Polycomb protein Ezh2 regulates pancreatic beta-cell Ink4a/Arf expression and regeneration in diabetes mellitus. Genes Dev 23:975-985
137. Harding HP, Novoa I, Zhang Y et al (2000) Regulated translation initiation controls stress-induced gene expression in mammalian cells. Mol Cell 6:1099-1108
138. Hartman MG, Lu D, Kim ML et al (2004) Role for activating transcription factor 3 in stress-induced beta-cell apoptosis. Mol Cell Biol 24:5721-5732 (Pubitemid 38787958)
139. Cnop M, Ladrière L, Igoillo-Esteve M, Moura RF, Cunha DA (2010) Causes and cures for endoplasmic reticulum stress in lipotoxic β-cell dysfunction. Diabetes Obes Metab 12(Suppl 2):76-82
140. AkiyamaM, LiewCW, Lu S et al (2013) X-box binding protein 1 is essential for insulin regulation of pancreatic α-cell function. Diabetes 62:2439-2449
141. Allagnat F, Christulia F, Ortis F et al (2010) Sustained production of spliced X-box binding protein 1 (XBP1) induces pancreatic beta cell dysfunction and apoptosis. Diabetologia 53:1120-1130
142. Anello M, Lupi R, Spampinato D et al (2005) Functional and morphological alterations of mitochondria in pancreatic beta cells from type 2 diabetic patients. Diabetologia 48:282-289 (Pubitemid 40543300)
143. Liu S, Okada T, Assmann A et al (2009) Insulin signaling regulates mitochondrial function in pancreatic beta-cells. PLoS One 4:e7983
144. Peshavaria M, Larmie BL, Lausier J et al (2006) Regulation of pancreatic beta-cell regeneration in the normoglycemic 60% partial-pancreatectomy mouse. Diabetes 55:3289-3298 (Pubitemid 44923585)
145. Menge BA, Tannapfel A, Belyaev O et al (2008) Partial pancreatectomy in adult humans does not provoke beta-cell regeneration. Diabetes 57:142-149
146. Menge BA, Breuer TG, Ritter PR, Uhl W, Schmidt WE, Meier JJ (2012) Long-term recovery of β-cell function after partial pancreatectomy in humans. Metabolism 61:620-624
147. Salpeter SJ, Khalaileh A, Weinberg-Corem N, Ziv O, Glaser B, Dor Y (2013) Systemic regulation of the age-related decline of pancreatic β - cell replication. Diabetes 62:2843-2848
148. Bernal-Mizrachi E, Kulkarni RN, Scott DK, Mauvais-Jarvis F, Stewart AF, Garcia-Ocaña A (2014) Human β-cell proliferation and intracellular signaling part 2: still driving in the dark without a road map. Diabetes 63:819-831
149. Vetere A, Choudhary A, Burns SM, Wagner BK (2014) Targeting the pancreatic β-cell to treat diabetes. Nat Rev Drug Discov 13:278-289